AGVHD
Clinical trials for AGVHD explained in plain language.
Never miss a new study
Get alerted when new AGVHD trials appear
Sign up with your email to follow new studies for AGVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for transplant patients battling dangerous immune reaction
Disease control Not yet recruitingThis study is testing whether adding an experimental drug called Gecacitinib to standard steroid treatment can better control acute Graft-Versus-Host Disease (aGVHD) in adults who recently received a stem cell transplant. The trial will enroll 25 patients with moderate to severe …
Matched conditions: AGVHD
Phase: PHASE2 • Sponsor: Bin Gu • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC
-
New drug trial aims to stop dangerous transplant complication
Prevention Not yet recruitingThis study is testing whether a drug called ivarmacitinib can prevent acute graft-versus-host disease (aGVHD) in people with blood cancers who receive stem cell transplants from partially matched donors. The trial will enroll 32 patients to see how well the drug prevents moderate…
Matched conditions: AGVHD
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Prevention
Last updated Mar 02, 2026 15:24 UTC